Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Citi
Federal Trade Commission
Colorcon
US Department of Justice
Accenture
Boehringer Ingelheim
Merck
Teva

Generated: July 20, 2018

DrugPatentWatch Database Preview

Auxilium Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for AUXILIUM PHARMS, and when can generic versions of AUXILIUM PHARMS drugs launch?

AUXILIUM PHARMS has eleven approved drugs.

There are eleven US patents protecting AUXILIUM PHARMS drugs.

There are one hundred and seventeen patent family members on AUXILIUM PHARMS drugs in thirty-eight countries.

Summary for Auxilium Pharms
International Patents:117
US Patents:11
Tradenames:10
Ingredients:7
NDAs:11

Drugs and US Patents for Auxilium Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Auxilium Pharms Llc THEO-24 theophylline CAPSULE, EXTENDED RELEASE;ORAL 087943-001 Aug 22, 1983 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-004 Jun 12, 1997 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-006 Jul 30, 1998 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-007 Jul 30, 1998 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Auxilium Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Auxilium Pharms Llc SEMPREX-D acrivastine; pseudoephedrine hydrochloride CAPSULE;ORAL 019806-001 Mar 25, 1994 4,501,893 ➤ Try a Free Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 5,023,252 ➤ Try a Free Trial
Auxilium Pharms Llc SEMPREX-D acrivastine; pseudoephedrine hydrochloride CAPSULE;ORAL 019806-001 Mar 25, 1994 4,650,807 ➤ Try a Free Trial
Auxilium Pharms Llc STRIANT testosterone TABLET, EXTENDED RELEASE;BUCCAL 021543-001 Jun 19, 2003 4,615,697 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for AUXILIUM PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Gel 1% ➤ Subscribe 2008-08-21

Non-Orange Book US Patents for Auxilium Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,765,177 Bioadhesive progressive hydration tablets ➤ Try a Free Trial
6,126,959 Pharmaceutical composition for treating dysmenorrhea and premature labor ➤ Try a Free Trial
6,699,494 Pharmaceutical composition and method for treating premature labor ➤ Try a Free Trial
7,153,845 Bioadhesive progressive hydration tablets ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Covington
Federal Trade Commission
AstraZeneca
Healthtrust
Fuji
Boehringer Ingelheim
Teva
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.